Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
BMC Cancer|May 26, 2021
Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancerIlario Giovanni Rapposelli, Valentina Zampiga, Ilaria Cangini, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 2019
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
Clinical Lung Cancer|August 27, 2024
The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active TreatmentChiara Bennati, Roberto Ferrara, Sabina Sangaletti, et al.
Oncotarget|April 28, 2016
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancerAlessandro Passardi, Emanuela Scarpi, Luigi Cavanna, et al.
BMJ Open|July 22, 2020
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocolAlberto Bongiovanni, Chiara Liverani, Sara Pusceddu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 10, 2024
Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trialsMauro Stefano, Daniele Perrina, Carlo Vallicelli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2017
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional StudyGiorgio Bogani, Laura Matteucci, Stefano Tamberi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2025
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)Giuseppe Maglietta, Angela Damato, Silvia Finotto, et al.
Cancer|August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma GroupFederica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
Oncotarget|February 20, 2016
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR groupAndrea Casadei Gardini, Emanuela Scarpi, Giorgia Marisi, et al.
Pageof 9